141 related articles for article (PubMed ID: 23176150)
21. Clinical pharmacodynamics of meropenem in patients with lower respiratory tract infections.
Li C; Du X; Kuti JL; Nicolau DP
Antimicrob Agents Chemother; 2007 May; 51(5):1725-30. PubMed ID: 17307978
[TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetics of meropenem and piperacillin in critically ill patients with indwelling surgical drains.
Adnan S; Li JX; Wallis SC; Rudd M; Jarrett P; Paterson DL; Lipman J; Udy AA; Roberts JA
Int J Antimicrob Agents; 2013 Jul; 42(1):90-3. PubMed ID: 23590897
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics of continuous-infusion meropenem for the treatment of Serratia marcescens ventriculitis in a pediatric patient.
Cies JJ; Moore WS; Calaman S; Brown M; Narayan P; Parker J; Chopra A
Pharmacotherapy; 2015 Apr; 35(4):e32-6. PubMed ID: 25884534
[TBL] [Abstract][Full Text] [Related]
24. The effect of borneol on the concentration of meropenem in rat brain and blood.
Xin HL; He XR; Li W; Zhou ZD; Zhang S; Wang GJ
J Asian Nat Prod Res; 2014; 16(6):648-57. PubMed ID: 24827508
[TBL] [Abstract][Full Text] [Related]
25. Antibiotics in acute pancreatitis. Current status and future directions.
Bradley EL
Am J Surg; 1989 Nov; 158(5):472-7; discussion 477-8. PubMed ID: 2683821
[TBL] [Abstract][Full Text] [Related]
26. Penetration of meropenem into epithelial lining fluid of patients with ventilator-associated pneumonia.
Lodise TP; Sorgel F; Melnick D; Mason B; Kinzig M; Drusano GL
Antimicrob Agents Chemother; 2011 Apr; 55(4):1606-10. PubMed ID: 21300830
[TBL] [Abstract][Full Text] [Related]
27. Population pharmacokinetics and pharmacodynamics of meropenem in pediatric patients.
Du X; Li C; Kuti JL; Nightingale CH; Nicolau DP
J Clin Pharmacol; 2006 Jan; 46(1):69-75. PubMed ID: 16397286
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of Meropenem Penetration into Cerebrospinal Fluid in Patients with Meningitis After Neurosurgery.
Zhang Y; Zhang J; Chen Y; Yu J; Cao G; Wu X; Chen M; Wu J; Zhao X
World Neurosurg; 2017 Feb; 98():525-531. PubMed ID: 27867128
[TBL] [Abstract][Full Text] [Related]
29. Pharmacodynamics of ceftazidime and meropenem in cerebrospinal fluid: results of population pharmacokinetic modelling and Monte Carlo simulation.
Lodise TP; Nau R; Kinzig M; Drusano GL; Jones RN; Sörgel F
J Antimicrob Chemother; 2007 Nov; 60(5):1038-44. PubMed ID: 17785282
[TBL] [Abstract][Full Text] [Related]
30. Steady-state pharmacokinetics and pharmacodynamics of meropenem in hospitalized patients.
Cheatham SC; Kays MB; Smith DW; Wack MF; Sowinski KM
Pharmacotherapy; 2008 Jun; 28(6):691-8. PubMed ID: 18503396
[TBL] [Abstract][Full Text] [Related]
31. Ceftriaxone bone penetration in patients with septic non-union of the tibia.
Garazzino S; Aprato A; Baietto L; D'Avolio A; Maiello A; De Rosa FG; Aloj D; Siccardi M; Biasibetti A; Massè A; Di Perri G
Int J Infect Dis; 2011 Jun; 15(6):e415-21. PubMed ID: 21497532
[TBL] [Abstract][Full Text] [Related]
32. Bioequivalence, antibacterial activity and therapeutic outcome of a generic meropenem (Mapenem).
Leelarasamee A; Rongrungruang Y; Trakulsomboon S; Pongpech P; Thanawattanawanich P; Jithavech P
J Med Assoc Thai; 2008 Jul; 91(7):980-8. PubMed ID: 18839835
[TBL] [Abstract][Full Text] [Related]
33. Steady-state pharmacokinetics and pharmacodynamics of cefepime administered by prolonged infusion in hospitalised patients.
Cheatham SC; Shea KM; Healy DP; Humphrey ML; Fleming MR; Wack MF; Smith DW; Sowinski KM; Kays MB
Int J Antimicrob Agents; 2011 Jan; 37(1):46-50. PubMed ID: 21074370
[TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetics of 5-fluorouracil and its penetration into pancreatic juice in dogs.
Zhu Z; Fu Q; Nightingale CH; Zhao YP; Liao Q; Wang HN; Xue CQ; Yang ZY; Li DK
Zhongguo Yao Li Xue Bao; 1998 Jan; 19(1):7-9. PubMed ID: 10375748
[TBL] [Abstract][Full Text] [Related]
35. Comparison of 30-min and 3-h infusion regimens for imipenem/cilastatin and for meropenem evaluated by Monte Carlo simulation.
Lee LS; Kinzig-Schippers M; Nafziger AN; Ma L; Sörgel F; Jones RN; Drusano GL; Bertino JS
Diagn Microbiol Infect Dis; 2010 Nov; 68(3):251-8. PubMed ID: 20851549
[TBL] [Abstract][Full Text] [Related]
36. [Pancreas penetration by ofloxacin--a pilot study].
Koch K; Drewelow B; Brinckmann W
Z Gastroenterol; 1993 Oct; 31(10):587-91. PubMed ID: 8256472
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety of meropenem (3 g daily) in Japanese patients with refractory respiratory infections.
Kawanami T; Mukae H; Noguchi S; Yamasaki K; Akata K; Ishimoto H; Matsumoto K; Morita K; Yatera K
J Infect Chemother; 2014 Dec; 20(12):768-73. PubMed ID: 25193038
[TBL] [Abstract][Full Text] [Related]
38. [Penetration of ciprofloxacin and cefoperazone into human pancreas].
Jiang L; Peng Q; Yao Y
Hua Xi Yi Ke Da Xue Xue Bao; 1997 Dec; 28(4):365-8. PubMed ID: 10683947
[TBL] [Abstract][Full Text] [Related]
39. Assessment of antimicrobial penetration into the pancreatic juice in dogs.
Miyamoto M; Sudo T; Kuyama T; Kawamura M
Nihon Geka Hokan; 1990 May; 59(3):205-10. PubMed ID: 2130783
[TBL] [Abstract][Full Text] [Related]
40. [Pancreatic penetration of antibiotics].
Koch K; Drewelow B; Liebe S; Reding R; Riethling AK
Chirurg; 1991 Apr; 62(4):317-22. PubMed ID: 1860357
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
